The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have opened a call for evidence to evaluate the impact of resources developed under the Wellcome-funded Digital Mental Health Technologies (DMHT) programme. The survey opened on 5 November 2026 and will close on 26 February 2027.
Who is being asked to respond
The two organisations are inviting feedback from a broad set of stakeholders: developers and manufacturers of digital mental health technologies, healthcare professionals, researchers, policymakers, regulators, people with lived experience of mental health conditions, carers and members of the public. Respondents are encouraged to take part whether their engagement with the existing materials has been extensive, minimal or none at all.
What the evaluation covers
The survey forms part of the programme's Phase 1 evaluation and is intended to establish how the resources have been received and used across the sector. MHRA and NICE said they are particularly interested in whether the materials have influenced users' knowledge, confidence, decision-making and professional practice.
The resources themselves were created to support the safe development, regulation, evaluation and adoption of digital mental health technologies, a category that includes mental health apps and other digital tools.
How the findings will be used
Results from the survey will help determine whether the Phase 1 outputs achieved their intended objectives and will inform the future direction of Phase 2 of the DMHT programme. According to the agencies, the feedback will also be used to identify strengths, highlight areas for improvement and shape subsequent work aimed at improving the safety and effectiveness of digital mental health technologies.